Sotera Health (SHC)
(Delayed Data from NSDQ)
$11.15 USD
-0.34 (-2.96%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $11.15 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SHC 11.15 -0.34(-2.96%)
Will SHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SHC
Strength Seen in PACS Group, Inc. (PACS): Can Its 21.8% Jump Turn into More Strength?
Sotera Health (SHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
SHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sotera Health Company (SHC) Q1 Earnings and Revenues Top Estimates
CareDx (CDNA) Tops Q1 Earnings Estimates
Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock?
Other News for SHC
Sotera Health Co (SHC) Announces Upcoming Release of Q2 2025 Financial Results | SHC stock news
Sotera Health Announces Second-Quarter 2025 Earnings Release Date | SHC Stock News
Shaftesbury Capital price target raised to 210 GBp from 208 GBp at Citi
BlackRock Increases Stake in Shaftesbury Capital
Sotera Health Company: Slow And Steady